Zyvex Pharmaceuticals Cardarine GW-501516 20 mg Research Pack
Out of stock
Injection · 50 mg · vial
Zyvex Pharmaceuticals GHK-CU is a copper-binding tripeptide in a 50 mg lyophilized vial, studied for collagen synthesis and wound repair in laboratory models rather than used as a licensed medicine. Available for purchase as GHK-CU 50 mg, a single research vial.
GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. GHK-CU for sale with international shipping in a 4 to 10 day transit window.
Zyvex Pharmaceuticals GHK-CU is a 50 mg lyophilized vial of the copper-binding tripeptide GHK-Cu, also listed as copper tripeptide-1. GHK is a naturally occurring three amino acid sequence that binds copper(II) in a one to one complex, and the project fact file describes it as a research peptide studied for collagen synthesis and wound repair, mostly in cell cultures, animal models and topical preparations. No human half-life and no validated human dose are recorded in the checked sources, which is why this vial is offered as laboratory material rather than a medicine.
GHK carries copper into tissue and appears in the wound-healing literature as a signal for collagen synthesis, antioxidant defence and a calmer inflammatory response. Plasma enzymes break the tripeptide down quickly, so most published work is done in culture or on skin rather than through systemic human dosing. In the catalogue it usually sits next to the repair peptides, such as the Zyvex BPC-157 5 mg vial and the systemic Zyvex TB-500, while the same substance is stocked in other lines as GHK-Cu 50 mg and GHK-CU 50 mg from Axiolabs.
Add bacteriostatic water down the wall of the vial and swirl, do not shake. The vendor guidance recorded in the fact file is 2 to 5 ml for a 50 mg vial, which works out at roughly 10 to 25 mg/ml. That is a measuring instruction for laboratory work and not a human dose, because no human dose has been validated. Keep the sealed powder cold and away from light, and the mixed solution in the refrigerator, where it is treated as short-lived.
Each batch is produced under GMP conditions and checked by HPLC, with the Certificate of Analysis held for the batch so the vial can be traced to its lot. Purchase this copper peptide here as a single 50 mg research vial for laboratory work; it is not licensed as a medicine for human use.
For laboratory research only. Consult a healthcare professional before use.
| Brand | Zyvex Pharmaceuticals |
| Active Substance | GHK-Cu copper tripeptide-1 |
| Dosage | 50 mg per vial |
| Package | 1 lyophilized vial |
| Form | Lyophilized powder, requiring reconstitution |
| Drug Class | Research peptide, no approved human indication |
| Manufacturing | GMP-certified |
| Testing | HPLC per batch, COA on file |
| Shipping | International, 4-10 days transit |
Before you ask
It is a 50 mg lyophilized vial of GHK-Cu, the copper-binding tripeptide also called copper tripeptide-1, supplied by Zyvex Pharmaceuticals as research material. The fact file for this card records that it is studied for wound healing and collagen synthesis, mostly in culture, animal models and topical work, with no human half-life and no validated human dose, which is why it is described as laboratory material rather than a medicine.
Add bacteriostatic water slowly down the inside wall of the vial and swirl it, do not shake, because a peptide foam loses material. The vendor guidance in the fact file is 2 to 5 ml for the 50 mg vial, which gives roughly 10 to 25 mg/ml. Keep the mixed solution in the refrigerator, protect it from light and treat it as short-lived once the powder has been dissolved.
No. The checked sources state plainly that a human half-life is not established, and the only dose figures in the file are research amounts used in models, not human doses. Because plasma enzymes degrade the tripeptide quickly, most published work uses cell cultures or topical preparations. Any human number quoted elsewhere for this peptide is extrapolation rather than measurement, so treat it as an open question.
Human safety data is thin because human data is thin, so no side-effect profile can be stated with confidence, and the fact file rates liver toxicity as low with no water retention. No WADA listing for the peptide was found in the sources checked for this card, but that is an observation about the files rather than a clearance, and anyone subject to testing should verify the current list before handling it.
The 50 mg vial is listed on this page as research material, with shipping and the pack selected above. At the last check the vial was out of stock and no price was printed for the offer, and international shipping is listed at 45.00 USD with a four to ten day transit window and handling of one to two business days.
Be the first to share your experience with Zyvex Pharmaceuticals GHK-CU 50 mg Copper Peptide Research Vial
Log in to write a reviewComplete the cycle
Out of stock
Out of stock
Out of stock